LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 58.94 | 770.25 | 8507 | 8444 | 1.0074 | 1.0043 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 61.16 | 770.25 | 8545 | 8892 | 0.9610 | 0.9776 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 61.16 | 770.25 | 9016 | 8892 | 1.0139 | 1.0079 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 63.39 | 770.25 | 8886 | 9326 | 0.9528 | 0.9733 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 63.39 | 770.25 | 9432 | 9326 | 1.0114 | 1.0063 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 65.61 | 770.25 | 9252 | 9736 | 0.9503 | 0.9723 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 65.61 | 770.25 | 9931 | 9736 | 1.0200 | 1.0109 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 67.83 | 770.25 | 9572 | 10078 | 0.9498 | 0.9724 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 67.83 | 770.25 | 10080 | 10078 | 1.0002 | 1.0001 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.05 | 770.25 | 10009 | 10413 | 0.9611 | 0.9790 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.05 | 770.25 | 10589 | 10413 | 1.0168 | 1.0089 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 72.27 | 770.25 | 10080 | 10730 | 0.9394 | 0.9673 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 72.27 | 770.25 | 10864 | 10730 | 1.0124 | 1.0065 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 74.50 | 770.25 | 10266 | 10991 | 0.9340 | 0.9647 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 74.50 | 770.25 | 11257 | 10991 | 1.0241 | 1.0125 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.75 | 770.25 | 10456 | 11262 | 0.9284 | 0.9620 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.75 | 770.25 | 11523 | 11262 | 1.0231 | 1.0118 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.98 | 770.25 | 10564 | 11518 | 0.9172 | 0.9562 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.98 | 770.25 | 11892 | 11518 | 1.0324 | 1.0164 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 81.20 | 770.25 | 10864 | 11766 | 0.9233 | 0.9598 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 81.20 | 770.25 | 12270 | 11766 | 1.0428 | 1.0214 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 83.42 | 770.25 | 10894 | 12031 | 0.9054 | 0.9505 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 83.42 | 770.25 | 12611 | 12031 | 1.0481 | 1.0239 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 85.64 | 770.25 | 11165 | 12287 | 0.9087 | 0.9526 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 85.64 | 770.25 | 13101 | 12287 | 1.0662 | 1.0324 | MN20160304_L02 | D15 |